Lesley Murray
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 9
- Acute Myeloid Leukemia Research 6
- Oncology top 2%
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 6
- Gastroenterology top 2%
- Cancer Research top 5%
-
- Children's Rights and Participation 11
-
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 9
-
- Lymphoma Diagnosis and Treatment 9
-
- Melanoma and MAPK Pathways 6
- Co-authors
- Tinya J. AbramsJulie M. CherringtonLeslie B. LeeNancy PryerChristine MartensKlaus P. HoeflichSteven H. SwerdlowJ A Habeshaw
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Lesley Murray
92 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Hematology 939
- Oncology 1.5k
- Genetics 568
- Gastroenterology 254
- Cancer Research 523
Countries citing papers authored by Lesley Murray
This map shows the geographic impact of Lesley Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Murray more than expected).
Fields of papers citing papers by Lesley Murray
This network shows the impact of papers produced by Lesley Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Murray. The network helps show where Lesley Murray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lesley Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 42 | |
| 6 | 2020 | 50 | |
| 7 | 2020 | 11 | |
| 8 | Maintenance of Functional CD57+Cytolytic CD4+T Cells in HIV plus Elite Controllers | 2019 | 0 |
| 9 | 2019 | 13 | |
| 10 | 2019 | 4 | |
| 11 | Designing a personalised case-based recommender system for mobile self-management of diabetes during exercise | 2017 | 3 |
| 12 | 2016 | 12 | |
| 13 | Researching and representing mobilities: transdisciplinary encounters | 2014 | 8 |
| 14 | 2012 | 45 | |
| 15 | 2009 | 385 | |
| 16 | 2009 | 144 | |
| 17 | 2009 | 104 | |
| 18 | IAP (inhibitor of apoptosis) antagonist inhibits orthotopic lung tumor growth | 2007 | 1 |
| 19 | 2006 | 185 | |
| 20 | Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer. | 2003 | 215 |
About Lesley Murray
Lesley Murray is a scholar working on Hematology, Geography, Planning and Development, Transportation, Genetics and Pathology and Forensic Medicine, having authored 94 papers that have together received 5.4k indexed citations. Recurring topics across this work include Children's Rights and Participation (11 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Melanoma and MAPK Pathways (6 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (939 citations), Oncology (1.5k citations), Genetics (568 citations), Gastroenterology (254 citations) and Cancer Research (523 citations). Lesley Murray has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Tinya J. Abrams, Julie M. Cherrington, Leslie B. Lee, Nancy Pryer, Christine Martens, Klaus P. Hoeflich, Steven H. Swerdlow, J A Habeshaw, Lori S. Friedman and Beth L. Hill. Their work appears in journals such as Mobilities, Blood, Bioorganic & Medicinal Chemistry Letters, Clinical Cancer Research and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.